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Abstract
We describe a human and large animal Langendorff experimental apparatus for live electrophysiological studies and measure the
electrophysiological changes due to gap junction uncoupling in human and porcine hearts. The resultant ex vivo intact human and
porcine model can bridge the translational gap between smaller simple laboratory models and clinical research. In particular,
electrophysiological models would benefit from the greater myocardial mass of a large heart due to its effects on far-field signal,
electrode contact issues and motion artefacts, consequently more closely mimicking the clinical setting. Porcine (n = 9) and
human (n = 4) donor hearts were perfused on a custom-designed Langendorff apparatus. Epicardial electrograms were collected
at 16 sites across the left atrium and left ventricle. A total of 1 mM of carbenoxolone was administered at 5 ml/min to induce
cellular uncoupling, and then recordings were repeated at the same sites. Changes in electrogram characteristics were analysed.
We demonstrate the viability of a controlled ex vivo model of intact porcine and human hearts for electrophysiology with
pharmacological modulation. Carbenoxolone reduces cellular coupling and changes contact electrogram features. The time from
stimulus artefact to (-dV/dt)max increased between baseline and carbenoxolone (47.9 ± 4.1–67.2 ± 2.7 ms) indicating conduction
slowing. The features with the largest percentage change between baseline and carbenoxolone were fractionation + 185.3%,
endpoint amplitude − 106.9%, S-endpoint gradient + 54.9%, S point − 39.4%, RS ratio + 38.6% and (-dV/dt)max − 20.9%. The
physiological relevance of this methodological tool is that it provides a model to further investigate pharmacologically induced
pro-arrhythmic substrates.
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Background
Ex vivo models
A major challenge for translational research in the cardiovas-
cular field is to effectively and efficiently translate research
from bench to bedside. In vitro and small animal disease
models in particular are limited in their recapitulation of the
human phenotype, with only a third of small animal research
studies resulting in positive translation to human randomised
trials [13]. Cell and small animal models are still an absolute
necessity in disease characterisation and safety assessment
before scaling up. This is due to their ability to control con-
founding factors and their relative simplicity. However, the
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limitations of these models must be recognised when extrap-
olating findings from such studies to human hearts [12]. Cell
models lack the myocardial mass to represent the effects
found in intact preparations, whilst smaller animal models
are anatomically and physiologically less comparable with
the clinic than large animals. Clinical research on the other
hand has the disadvantage that ethical and practical consider-
ations limit the procedures and techniques which can be per-
formed. Therefore, full characterisation and validation of cel-
lular factors and mechanistic insight cannot be obtained.
Explanted intact human and porcine hearts provide the ide-
al middle ground to bridge this translational gap in arrhythmia
research between simpler laboratory models and patients.
Despite the advantages of such models, the ethical and prac-
tical challenges of procuring these samples and sustaining
them in the laboratory have resulted in limited success of
implementing the model. The procedure for isolating and per-
fusing an intact animal heart ex vivo has remained largely
unchanged since it was developed for the frog heart in 1895
[11]. This is due to its efficacy at keeping the preparation
viable for several hours [15], which is sufficient for most data
acquisition protocols [21]. However, it is predominantly used
in rodent animal models only due to the complexities involved
in developing large animal and human Langendorff systems,
as well as challenges in the acquisition of these organs.
Although there have been previous attempts to carry out stud-
ies in intact ex vivo human hearts, these have been achieved in
only a handful of centres due to the aforementioned challenges
[7, 8, 16]. To date, nowork has been published on the utility of
this model for assessing the electrophysiology changes under
pharmacological intervention. This increases the potential use
of this model to mimic the pathological substrate.
The contact electrogram
The contact electrogram (EGM) is the signature of the inter-
action of electrical activation and architecture of the local
myocardium and is therefore the main data source in the clin-
ical cardiac catheter laboratory. During interventional proce-
dures to treat arrhythmias, electrodes between 2 and 4 mm in
size are held in direct contact with cardiac tissue and the po-
tential difference relative to a distant electrode is recorded
[17]. Healthy myocardium gives rise to an electrogram with
relatively simple morphology, but intra-cellular uncoupling or
ion channel abnormalities may produce a signal with more
complex, or fractionated, morphology [18]. The EGM is
categorised clinically by binary classifications, such as simple,
complex or early, late. This form of classification gives little
insight into the content of the signal itself and means much of
the information within the EGM is left unused [14]. This is
because defining the relationship between the characteristics
of the myocardial structure, its electrophysiology and the
EGM remains elusive. However, the EGMs produced from
more reductionist models which allow for controlled charac-
terisation are very different from those found in patients, since
the reduced cardiac myocardial mass lacks far-field signals,
motion artefacts and issues with proper contact. To investigate
the EGMs in a manner which is translatable to the clinic, we
need to overcome these in a controllable model which is as
close to in vivo as possible.
Clinical motivation
Atrial fibrillation (AF) is the most common form of cardiac
arrhythmia, affecting around 1.3 million people in the UK and
is associated with an increased risk of stroke, heart failure and
death [9]. Treatment of AF often involves catheter ablation,
which uses localised freezing or radiofrequency energy to
electrically isolate or destroy problematic regions of myocar-
dium and prevent the initiation and perpetuation of re-entrant
tachycardias or AF. Catheter ablation is the most effective
intervention strategy used for treating persistent AF.
However, despite attempts to improve the success rates
through clinical practice, patients found to be free from the
disease after 12–30 months following treatment can range
between only 20 and 60% [17].
Acute induction of the physiological consequences of ion
channel blockade and cellular uncoupling can be recapitulated
by pharmacological interventions. Carbenoxolone (CBX) is
one such agent that leads to gap junction uncoupling and
conduction discontinuity, therefore modelling pro-
arrhythmic properties. The porcine and human Langendorff
can be used to create a model comparing baseline with pro-
arrhythmic measurements in a controllable laboratory envi-
ronment. This in turn has the potential to provide a greater
understanding and improved interpretation of measurements
of the electrophysiological structure and function needed to
improve treatment outcomes. For mechanistic insight at a cel-
lular level, we investigated these effects in both the left ven-
tricle and left atrium. In this study, we aimed to demonstrate
the utility of the intact ex vivo porcine and human heart as a
model for high fidelity, controlled electrophysiological studies
with acute pharmacological modulation.
Methods
Heart acquisition
Human hearts were acquired once an explanted donor heart
within the UKwas deemed unsuitable for transplant and when
all other avenues of clinical usage had been exhausted (n = 4).
Information on the cause of death, reason for rejection and
ischaemic time was subsequently made available, along with
any further clinical data or necessary details (Table 1). The
samples were fully anonymised, and researchers had no access
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to identifiable data. Hearts were transported to the laboratory
in cardioplegia on ice by emergency medical courier.
Transport time was between 1 and 6 h, depending on location,
which is within the window of viability for a heart in
cardioplegia [1].
Porcine hearts (n = 9) were explanted from healthy large
white female pigs, weighing 70–80 kg and 4–5 months old.
Briefly, pigs were premedicated with intramuscular adminis-
tration of Ketamine (20 mg/kg) and Midazolam (0.5 mg/kg),
followed by intravenous administration of Propofol (2–
4 mg/kg). Anaesthesia was maintained using inhaled
Sevoflurane and intravenous constant rate infusion (CRI) of
Fentanyl (3μg/kg/h), followed by removal of the heart using a
human donor retrieval protocol [23]. Porcine hearts were also
transported in cardioplegia on ice to the laboratory within 1 h.
Langendorff apparatus
A custom-build Langendorff apparatus was constructed to
provide the necessary environment to keep the intact human
and porcine hearts alive outside the body for over 3 h, which is
sufficient for the electrophysiological data acquisition proto-
cols used in this study (Fig. 1a and b). The apparatus consisted
of a 5-l solution reservoir (custom supply from Radnoti Ltd.),
an oxygen supply to oxygenate the physiological solution to
maximal saturation, a heating coil to ensure the solution re-
mains at an optimal temperature of 37 ± 0.5 °C (custom sup-
ply from Radnoti Ltd.), a bubble trap to remove air pockets
from the system (custom supply fromRadnoti Ltd.) and a high
flow peristaltic pump to circulate solution around the system
at a constant rate (Cole Parmer, UK). The physiological solu-
tion was oxygenated Tyrode’s solution, used to flush out the
cardioplegia, warm the heart back to optimum temperature
levels and continuously provide the heart with the glucose
and ions necessary to recommence and then maintain electri-
cal activity and contraction [2].The solution chambers were
connected to an aortic cannula, where the normothermic and
oxygenated physiological solution was perfused into the cor-
onary arteries in a retrograde manner, thereby maintaining the
metabolic, electrical and contractile activity of the heart. The
perfusate exited the coronary circulation into the right atrium
and was subsequently expelled from the heart. Following the
initial period of cardioplegia washout and warming up, the
heart was cardioverted if needed using a defibrillator at 10–
50 mV. The heart was paced from the basal region of the left
ventricle at 10% above the threshold of activation (usually
2 mV) using a clinical stimulator (Micropace EP Inc., USA)
and monitored for 15–30 min to ensure full stabilisation and
reduction in ST segment elevation prior to recording.
Monitoring and recording
Following the warm reperfusion and stabilisation time, elec-
trogram recordings were carried out under steady pacing at 2-
5A of cycle lengths 300, 400, 500, 660, 750, 1000 and
1500 ms. Clinical HD grid mapping catheters (Abbot
Medical) (Fig. 1c), connected to an electrophysiological re-
cording system (PowerLab, AD Instruments) with the
Labchart software (AD Instruments), were used to record the
electrophysiological activity using a bandwidth of 0.3–500 Hz
and a 1-KHz sampling rate from multiple sites across the left
ventricular and left atrial epicardium (Fig. 1d). Single-lead
electrocardiogram (ECG) in the left ventricle, pressure and
temperature were also monitored throughout to assess and
enable adjustments to be made as necessary to maintain the
stability of the preparation.
Recordings were taken sequentially over 16 areas of the
epicardial surface of the left ventricle and the left atrium. A
high-resolution photograph is taken at each electrogram site to
record the specific position of the catheter’s electrode grid on
the epicardial surface (Fig. 1d and e). The positioning of the
catheter was superimposed on a 3D reconstruction of the heart
after the experiment using photogrammetry. After baseline
(BL) recordings at all sites, 50 ml of 1 mM CBX was admin-
istered through the aortic cannular, using a syringe driver at a
rate of 5 ml/min, to induce gap junction blockade. This result-
ed in a final circulating concentration of 0.01 mM in the total
5 l volume. Following CBX administration, the pacing proto-
col was repeated with contact EGM recordings obtained at the
same sites as baseline.
Electrogram post-processing and analysis
We developed signal processing algorithms to automatically
extract characteristics of the electrogram morphology for ev-
ery activation in the dataset in a consistent manner. The algo-
rithm was adapted for the intact heart from the one we
Table 1 The age, sex, reason for
rejection and cause of death for all
of the human donor hearts (n = 4)
Heart Donor age Donor sex Reason for rejection Cause of death
6 32 Female History of meningitis Haemorrhage
9 36 Male High lactate Drowning
11 51 Male Poor function Intracranial bleed
13 20 Male Malignancy found in pancreas Traffic accident (unrestrained passenger)
1437Pflugers Arch - Eur J Physiol (2020) 472:1435–1446
previously developed for the analysis of myocardial cell
monolayers [3].
A broad range of EGM signal time-domain features were
extracted for each individual recording. The 19 features in-
cluded were selected due to their known and established im-
portance in cardiac electrophysiology from EGM and ECG
interpretations, or as a region of interest previously investigat-
ed with myocardial cell monolayers that may provide further
mechanistic insight [3]. To validate the accuracy of the auto-
mated interpretation, randomly selected EGMswere manually
interpreted and compared with the feature extraction values.
Statistical analyses
Statistical analyses were carried out using the Prism 5.0 soft-
ware (GraphPad). Unless otherwise stated, T tests were per-
formed to compare BLwith CBX and p < 0.05was considered
statistically significant.
Results
Stability of the Langendorff model
All intact porcine and human hearts were successfully restarted
(n= 13). The preparations remained stable and allowed all desired
measurements and modulations to easily be performed in the time
duration of each experiment (Table 2). Heart 6 had an experiment
duration of 34 min because despite high preparation stability, it
had to be terminated prematurely due to external factors. A total of
5492 individual beats were measured and analysed.
Capture of electrophysiological data
When initially restarted, ST elevation was observed (Fig. 2a),
with reduction in the ischemic features after 15 min of
stabilisation (Fig. 2a). high-quality unipolar EGMswere success-
fully obtained from the epicardial surface of the left ventricle and
left atrium (Fig. 2b) in both the porcine and human hearts.
Fig. 1 a Diagram of the Langendorff apparatus. Blue: tubing for the
physiological solution. Red: tubing for the surrounding heating
solution. b The Langendorff apparatus, pump and aortic cannula
feeding into a porcine heart. c 4 × 4 HD grid catheter by Abbott
Medical, used to record the electrograms from the left ventricle and
atrium. d The locations on the epicardial surface from where the HD
grid catheter was placed to perform the pacing protocol. Positions 1–12
are on the epicardial surface of the left ventricle and positions 13–16 are
on the epicardial surface of the left atrium. e A photograph of a human
heart taken during the pacing protocol at BL to record the location of the
catheter when the EGMswere gathered. In this photograph, the catheter is
at position 3
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Pharmacological modulation of model
Initial assessment of the response to CBX for the progression
of cellular uncoupling on the EGM was by measuring the
increase in the time interval between the pacing stimulus to
time of (-dV/dt)max following the administration of 50 ml of
1 mMCBX over 10 min (Fig. 3a). The EGMmorphology and
time interval between pacing stimulus to time of (-dV/dt)max
of the donor heart at BL are closer to the porcine heart at BL
than following the administration of CBX (Fig. 3a). A mean
interval of 47.9 ± 4.1 ms was observed across all electrodes at
BL, whilst this interval increased to a mean of 67.2 ± 2.7 ms
after 50 ml of 1 mM carbenoxolone was administered. The
progression of CBX over the 10 min at 5 ml/min established
the maximal response, with 50 ml dose (equivalent to
30.735 mg) being selected for all subsequent analyses, as this
represented the maximal response, to investigate a pro-
nounced feature change (Fig. 3b).
a
b
Fig. 2 a Example ECG (i) when
initially restarted. (ii) Reduction
in ischemic features following
stabilisation. b Extracted unipolar
EGM traces from porcine and
human hearts, taken at baseline.
The porcine and human record-
ings were made from the same
anatomical locations in the left
ventricle and left atrium
Table 2 The experiment duration for all whole heart Langendorff
experiments performed (n = 13)






6* 34 Human donor
7 102 Porcine
8 90 Porcine
9 85 Human donor
10 88 Porcine
11 78 Human donor
12 98 Porcine
13 182 Human donor
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a
b
Fig. 3 a Electrogram traces from a porcine and human donor heart,
recorded from the same catheter position and paced at 750 cl. (i) The (-
dV/dt)max was measured 114.8 ms after the pacing stimulus, recorded
with a porcine heart at BL. (ii) The (-dV/dt)max was measured 164.1 ms
after the pacing stimulus, recorded with a porcine heart after 50 ml of
1 mM CBX administered over 10 min. (iii) The (-dV/dt)max was mea-
sured 108.6 ms after the pacing stimulus, recorded with a human donor
heart at BL. b Dose response curve for CBX. The mean time delay and
standard deviation from the pacing stimulus to the (-dV/dt)max, measured
from all electrodes in contact with the myocardium. The progression of
gap junction uncoupling caused by the administered CBX can be seen by
the increased time delay from the pacing stimulus to the (-dV/dt)max of the
myocardium as more CBX is administered
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Comparison of features between baseline and with
carbenoxolone administered
Following the automated extraction of the EGM characteris-
tics at BL and with CBX added, the mean value and SD for
each feature were calculated (Table 3). Q point amplitude, R
point amplitude, S point amplitude, endpoint amplitude, S-
endpoint gradient, fractionation index, RS ratio, RS width/
EGM duration and amplitude were found to show statistical
significance between BL and CBX (Fig. 4a).
The features with the largest percentage change from BL to
with CBX were fractionation + 185.3%, endpoint amplitude
− 106.9%, S-endpoint gradient + 54.9%, S point − 39.4%, RS
ratio + 38.6% and (-dV/dt)max − 20.9% (Fig. 4b).
Discussion
We have demonstrated the ability to successfully restart and
sustain intact human and porcine hearts for over 3 h using our
custom Langendorff preparation, showing its viability to be
used as an ex vivo translational model to perform a variety of
electrophysiological investigations. Contact EGM recordings
were recorded from the hearts over this duration and pharma-
cological modulators can be used to investigate pathological
substrates.
Until recently, the only human myocardium available for
ex vivo analysis, if removed at the time of cardiac surgery,
was very small samples of diseased human myocardium.
Whilst providing essential information on cellular level activ-
ity, these samples have very little scope for comparison
against a healthy myocardium and could not be used to inves-
tigate organ-level physiological processes and disease states
that rely on the coordination, or mal-coordination, of different
areas of the myocardium. Therefore, for a comprehensive
analysis of these pathologies, intact preparations are neces-
sary. There is clear evidence to suggest that large animal car-
diac models more closely approximate human physiology
than cell and animal models [6, 22] and there is a general
acceptance that porcine hearts are similar to human [5, 19].
However, there are still some minor anatomical differences to
consider, along with other factors such as immunological tol-
erance [10]. Despite these differences, we have demonstrated
the development of an acute pathological model in the intact
ex vivo human heart.
Stability of preparation
We have demonstrated the use of the Langendorff appa-
ratus for translational research with ex vivo human and
porcine hearts. It enables the acquisition of unprecedented
high-fidelity electrophysiological data in a manner that is
otherwise impossible, giving rare insight into human dis-
ease states in a controlled ex vivo setting and allowing us
to perform high resolution, controlled electro-anatomical
characterisation. This system can maintain porcine and
Table 3 The mean, standard
deviation and percentage change
of each feature at BL and with
CBX. T tests have been
performed to determine if the
changes in features are
statistically significant
Feature BL mean (SD) CBX mean (SD) p value Percentage change (%)
RS interval 182.01 (1093.43) 149.96 (1061.53) 0.42 − 17.61
QR interval 68.59 (154.71) 63.21 (164.99) 0.34 − 7.84
QS interval 250.60 (1151.87) 213.17 (1159.46) 0.37 − 14.94
EGM duration 292.98 (1155.80) 265.20 (1163.59) 0.51 − 9.48
Q point 0.81 (0.96) 0.92(1.05) 0.002* 13.86
R point 3.13 (7.92) 2.55 (2.12) 0.03* − 18.60
S point − 3.40 (3.06) − 4.74 (2.66) p < 0.0001* − 39.40
Endpoint amplitude − 0.24 (2.02) − 0.50 (2.14) 0.0005* − 106.85
RS gradient − 0.31 (1.01) − 0.36 (0.33) 0.11 − 17.79
QR gradient 0.06 (0.24) 0.06 (0.10) 0.91 − 1.49
S-endpoint gradient 0.17 (0.29) 0.26 (1.40) p < 0.0001* 54.93
Fractionation index 29.27 (89.76) 83.52 (327.44) p < 0.0001* 185.30
R width 159.59 (613.57) 138.19 (635.67) 0.34 − 13.41
S width 133.39 (553.10 127.01 (127.01) 0.75 − 4.78
RS ratio − 1.35 (1.81) − 0.83 (1.06) p < 0.0001* 38.58
RS width ratio 1.95 (4.28) 1.97 (8.06) 0.91 1.04
RS width/EGM duration 0.50 (0.21) 0.48 (0.23) 0.005* − 4.30
(-dV/dt) max 2.17 (7.83) 1.72 (2.01) 0.08 − 20.94
Amplitude 6.53 (9.39) 7.28 (3.21) 0.02* 11.58
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human whole hearts in a stable preparation for a duration
sufficient to perform all planned data acquisition and can
therefore be used to help provide a greater understanding
of the electrophysiological structure and function of the
heart. Although all the human donor hearts received were
deemed unsuitable for transplant, there were variations in
the cause of death, reason for rejection and consequently
the condition of the hearts received (Table 1). Heart 11
Fig. 4 a The mean and SD of each feature extracted at BL and with CBX added. b The percentage change in EGM features from BL following the
administration of 1 mM CBX
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was deemed unsuitable for transplant due to poor cardiac
function, but the heart was successfully restarted and
sustained on the Langendorff for an experiment length
of 72 min, where all protocols were completed. The max-
imum investigation length recorded was 182 min on heart
13, at which point the human preparation was still stable
and the duration was only limited by the time scale needed
to complete the experimental protocol. This demonstrated
that although the human hearts were unsuitable for trans-
plants, they possessed the stability required for the study.
The shortest recorded length was 34 min from heart 6.
Despite the high stability of the preparation, it had to be
terminated prematurely due to staff health and safety con-
cerns. There was a possibility that a class 2 pathogen may
have been present in the heart, which was not indicated
until after initiation of the experiment. The stability of
the preparation beyond the current experimental investiga-
tion protocol length allows for further study to expand
beyond the scope of the existing protocol, with plans to
include additional methodologies to the data acquisition.
Utility of the preparations as an electrophysiological
and contractility model
The ability to restart human and porcine hearts in a stable
environment allows for finely controlled experimental condi-
tions and the use of techniques to a higher fidelity than is
possible in vivo. A stable controllable environment coupled
with large intact hearts forms a closer translational model than
is possible with cell or small animal models. The ex vivo
model has the potential to be used for a variety of electrophys-
iological investigations, such as optical mapping for cellular
electrophysiology, cardiac autonomic innervation and
engineered heart tissue implantation to repair heart tissue dam-
age. The preparation also enables investigations beyond elec-
trophysiology, such as heart contractility and valve research to
improve cardiac device design [8].
Pharmacological modulation
We have previously used pharmacological modulators in
simpler tissue and cell models to demonstrate modifica-
tions to ion channels and cellular coupling can be
interpreted in the EGM [4]. Investigating these abnor-
malities in ex vivo intact hearts may provide insight
into arrhythmogenic mechanisms. CBX causes cellular
uncoupling and therefore artificially reproduces a pro-
arrhythmic substrate. We delivered 50 ml of 1 mM
CBX retrogradely into each heart via a bolus to the
aorta using a syringe driver at a rate of 5 ml/min for
10 min. An alternate method of delivery for CBX
would be to switch to a second 5-l reservoir filled with
CBX-infused Tyrode’s solution at the final concentra-
tion. The bolus delivery method was preferred due to
the direct delivery of the CBX to the aorta allowing for
more precise measurement and incremental delivery of
dosage delivered over the 10 min of infusion, enabling
investigation of the dose response. Analysis of the EGM
has revealed that during the 10 min of CBX infusion,
there is an increase in the delay of the action potentials,
with progression of the delay following an s-curve (Fig.
3b). The characteristic EGM morphology represents the
variability in the electric field recorded at the electrodes,
produced by the movement of ions across myocardial
cell membranes, and the subsequent propagation of the
action potential [18]. Since the contact EGM measures
the electrical activity of the local myocardium, changes
in cellular electrophysiology manifest in the electrogram
morphology. The effects of cellular uncoupling on the
myocytes are visible on the contact electrogram and our
delivery method of CBX gives the expected effect at the
dosage administered. The method of delivery would
work for other drugs, and their effect on the cellular
electrophysiology would be represented on the EGMs.
Fig. 4 (continued)
1443Pflugers Arch - Eur J Physiol (2020) 472:1435–1446
Feature analysis
Analysis of the features of the EGMs was performed as a
percentage change from BL. This enabled the human hearts
to be compared together and with the porcine hearts.
Performing the analysis in this manner meant that there was
greater confidence that the changes we observed are a result of
the CBX administered. When comparing the EGM of a donor
heart at BL to a porcine heart at BL or with CBX (Fig. 3a), the
EGMmorphology of the donor heart was closer to the porcine
heart at BL, suggesting that the donor hearts do not present
with pro-arrhythmic substrates at baseline. The interval from
the stimulus artefact to (-dV/dt)max was 108.6 ms for a human
donor heart at BL, 114.8 ms with a porcine heart at BL and
164.1 ms with a porcine heart after CBX was administered.
The features of the EGMs with the largest percentage change
found from BL to with CBX were the fractionation index,
endpoint amplitude, S-endpoint gradient, S point, RS ratio
and (-dV/dt)max. Fractionation is a feature of the electrogram
which is measured clinically [20] and is thought to be associ-
ated with cell-to-cell discontinuity. Therefore, it is unsurpris-
ing that cellular uncoupling leads to an increase in fraction-
ation, and is consistent with our previous findings [4].
We have identified further features of the electrogram not
previously associated with cellular uncoupling. Due to their
large change in morphology with cellular uncoupling, these
features could be used when interpreting the EGMs to identify
the underlying pathology. The underlying electrophysiologi-
cal dysfunction associated with atrial fibrillation and other
arrhythmias cannot be characterised solely by gap junction
uncoupling; to establish the relationship between the changes
in EGM morphology and arrhythmia, the other substrates as-
sociated with arrhythmia must also be investigated.
Our Langendorff apparatus can be used to administer other
pharmacological modulators to investigate other arrhythmo-
genic substrates, such as ion channel blockers [4]. Identifying
the features with most significant changes from BL in these
EGMs could be used to establish collectively which combina-
tion of features differentiate between normal and different
specific pathological EGMs, leading to a greater understand-
ing of how pathological myocardial electrophysiological func-
tion manifests in the clinically accessible EGM. To leverage
the analysis of the EGMs, there is potential to apply machine
learning techniques to automatically distinguish more subtle
changes in EGMmorphology between a variety of underlying
pathologies [3]. Due to the ex vivo preparation’s similarities to
patients, with regard to size and baseline electrophysiological
properties, the machine learning model could be applied to
detect the same subtle changes in in vivo EGMs. This has
the potential to be translated into a diagnostic tool by targeting
regions of functional abnormalities during ablation procedures
to treat arrhythmias by providing clinicians with real-time
analysis of the EGMs they are collecting.
Limitations
A possible limitation of this model is that the human donor
hearts we receive have been deemed unsuitable for transplant,
due to acute abnormalities, in contrast to the healthy porcine
hearts. These donor hearts therefore may have a different
baseline to healthy human hearts. We have attempted to cor-
rect for this by using a percentage change from BL, to account
for any intrinsic BL differences. Clinically, EGMs are routine-
ly recorded from the endocardial surface. However, in the
absence of clinical 3D electroanatomic mapping systems, pre-
cise endocardial positioning of the catheter would be challeng-
ing on the heart ex vivo. We have instead recorded from the
epicardial surface for better control over catheter positioning
and so that the positioning can also be easily recorded with
photographs for reference.
Conclusion
In this study of ex vivo intact human and porcine hearts, we
have demonstrated that we can restart, maintain, pharmaco-
logically modulate and electrophysiologically interrogate
these large hearts using a custom-built Langendorff apparatus,
along with the possibility to expand the scope of existing
experiments further, such as the inclusion of optical mapping.
The effect of cellular uncoupling is visible on the EGM. With
the administration of other pharmacological modulations to
reproduce other pro-arrhythmic substrates by ion channel
blockade, the features of the EGM have the potential to dif-
ferentiate between normal and pro-arrhythmic and could be of
benefit to guide ablation procedures.
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